CHRS·19249H103·US·equity·Healthcare - Biotechnology-13D/G
CHRS (COHERUS ONCOLOGY INC) is held by 90 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($17.5M), GEODE CAPITAL MANAGEMENT, LLC ($5.3M), STATE STREET CORP ($3.9M). Net institutional sentiment: Mixed.
See how CHRS's score breaks down across 4 SEC sources
Showing 1-20 of 96
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer